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Summary
Rationale: Minimum tibiofemoral joint space width in the medial compartment (JSW) is the most well-established structural outcome measure
for osteoarthritis (OA) of the knee. Its usefulness as a measure of therapeutic effectiveness in short-term studies is limited by the rate and
variability of joint space narrowing (JSN) in the OA population. Microfocal radiography has been shown to improve reproducibility of JSW mea-
surement compared to standard radiography, but measurement of magniﬁcation from microfocal knee ﬁlms has been problematic, and JSN is
yet to be investigated in a longitudinal microfocal study.
Objective: To establish the effect on JSW reproducibility of a new method of magniﬁcation measurement in microfocal radiographs. To report
on and compare rates of medial tibiofemoral JSN and their variations in the placebo arms of microfocal and standard radiographic clinical trials
in OA, using ﬂuoroscopic semi-ﬂexed (SF) knee positioning. To place in the context of published estimates of rates of JSN from comparable
studies.
Methods: Using microfocal radiography, 36 patients were followed at a single centre for 2 years. Using standard radiography, 86 patients were
followed for 1 year at a single centre, and 549 for 2 years in a multi-centre international study. Computerised JSW measurement was under-
taken using enhanced and automated versions of existing algorithms. Rates of JSN were examined in the context of a review of published
rates of JSN using a variety of techniques.
Results: Reproducibility of JSW measurement from microfocal radiographs was improved by the new magniﬁcation measurement. Rates of
JSN were similar across the studies, but more variable when using standard radiography. The rates of JSN were also consistent with those
from previously published investigations; all estimates since 2000, bar one, being consistent with the value 0.05 mm/year.
Conclusion: Microfocal radiography using the new method lowered the variability of the rate of JSN, but the high cost and low availability of
microfocal equipment remains a barrier to its more widespread use. The consistently low but highly variable rates of JSN seen in the review
suggest that continued attempts to improve radiographic and mensural techniques are unlikely to signiﬁcantly reduce required sample sizes.
ª 2007 Published by Elsevier Ltd on behalf of Osteoarthritis Research Society International.
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Osteoarthritis (OA) of the knee is estimated to affect up-
wards of 10% of the population, making it the most common
form of arthritis in the world today1. OA is characterised by
general degradation and focal loss of articular cartilage,
periarticular osteophyte formation, subchondral bone
changes, and occasionally synovitis2. It is associated with
signiﬁcant pain and disability, and is a major factor leading
to prosthetic replacement of failed joints in particular the hip
and knee1. To date there has been very limited success
in demonstrating disease modiﬁcation in clinical trials of
potential therapies, established therapies therefore being
directed towards symptom control3.
Tibiofemoral joint space width in the medial compartment
(JSW), measured from plain radiographs, has been shown
to be a surrogate for cartilage loss4. On the strength of this,
much attention has been given to investigating and reﬁning
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330to developing radiographic methods designed to improve
the reproducibility and clinical signiﬁcance of the measure-
ment. As such, and also due to the relatively low cost and
high availability of radiographic equipment, JSW measure-
ment (referring in this paper only to measurement from
the medial tibiofemoral compartment) remains the most
well-established structural outcome measure for clinical
trials in OA5,6.
In 1995, a study which looked at the effect of various ra-
diographic and mensural procedures on reproducibility of
JSW measurement concluded that it was improved by
each of two radiographic procedures: the use of ﬂuoro-
scopic positioning in the semi-ﬂexed (SF) view (compared
to traditional fully extended positioning); and the use of
high magniﬁcation radiography (compared to standard radi-
ography)7. However, the practicality of using microfocal ra-
diography and to a lesser extent ﬂuoroscopy in large clinical
trials is limited by the fact that additional equipment is
required over and above that found in a typical hospital
X-ray suite8e10. The impact of such reduced practicality is
dependent on the effect that any concomitant improvement
in measurement reproducibility has on the number of knees
required to power a study.
Regarding the ﬁrst of these factors, a considerable
amount of research has since been conducted with the
Table I
Patient data for studies M (microfocal radiography), S1 (standard
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positioning protocols11,12. Such research has come to focus
not only on measurement reproducibility but also on the rate
of joint space narrowing in the medial compartment (JSN)
detected by each protocol13. This reﬂects the fact that the
number of knees required for a clinical trial depends on
the expected drug effect, the statistical power and signiﬁ-
cance required, and the rate and variability of JSN in the
study population14. Of these factors, only the last is affected
by the knee-positioning protocol used. Reproducibility of
JSW measurement affects study size as a component of
the variability of the rate of JSN, which has a second com-
ponent due to the actual variability of the rate in the popula-
tion15. This research has led to a steady improvement in the
quality of JSW measurement over the years, to the point
where a variety of non-ﬂuoroscopic methods are available
and have been recommended, in particular the ‘MTP’
view11 and the ‘ﬁxedeﬁxed’ view12,16 (which were based
on the ﬂuoroscopic SF17 and LyoneSchuss (LyS) proto-
cols18, respectively).
The studies presented here relate to the second radio-
graphic factor mentioned above, microfocal and standard
radiography as used in SF knee trials. To date, the lesser
availability of microfocal equipment has been considered
a signiﬁcant enough drawback that there have been no re-
sults published from clinical trials using the microfocal
method, while several have used standard radiography.
The chief advantage of microfocal radiography is its spatial
resolution, of the order of 10e100 mm as opposed to
300e1000 mm for standard radiography19. While this has
been shown to have an effect on the reproducibility of
JSW measurement7, and hence implicitly on the variability
of the rate of JSN, there has to date been no longitudinal
study of rates of JSN measured using microfocal radiogra-
phy. The ﬁrst such study is presented here, together with
rates of JSN from new studies of JSN measured from stan-
dard radiographs, including the largest such study to date.
The studies introduced improvements to the JSW mea-
surement procedures, designed to facilitate large trials by
facilitating quality assurance processes and measurement
automation. One such improvement, to the method of mag-
niﬁcation measurement in the microfocal case, was addi-
tionally expected to improve the reproducibility of JSW
measurement. Previous work had used ﬁne wire meshes at-
tached to the anterior and posterior surfaces of the knee7,
but these had been difﬁcult to locate and measure in the
resulting radiographs. The new method was based on one
using metal balls, which was already in use in standard
radiography7.
Rates of JSN in the placebo arms of clinical trials which
were conducted using the SF protocol are presented, and
discussed in the context of those from comparable previous
published studies by estimating conﬁdence intervals (CIs)
from the published data, with the aim of assessing the likely
future of tibiofemoral JSW measurement as an outcome
measure in clinical trials.radiography, 1-year single-centre), and S2 (standard radiography,
2 year multi-centre: North American (NA) and European (EU)
arms, and combined)
Study Number of
knees
Female:
Male ratio
Age
mean (SD)
BMI
mean (SD)
M 36 58:42 51.9 (8.4) 28.0 (4.9)
S1 86 77:23 62.6 (8.6) 30.2 (3.8)
S2 (NA) 269 72:28 61.9 (9.2) 29.5 (4.5)
S2 (EU) 280 71:29 62.3 (7.8) 29.5 (4.3)
S2 (all) 549 71:29 62.1 (8.6) 29.5 (4.4)Patients and methods
The knees measured constituted the placebo arms of three prospective
double-blind clinical trials in OA knees, in which the rate of JSN in a signal
knee was an outcome measure. All three studies used the SF knee posi-
tion17 and all radiographs were sent to a Central Analysis Facility at Guy’s
Hospital for digitisation and measurement. All patients provided written in-
formed consent before entering the studies. In cases where both knees sat-
isﬁed the inclusion and exclusion criteria described below, the knee with the
lesser JSW was selected to be the signal knee.MICROFOCAL RADIOGRAPHIC STUDY (STUDY M)Following ethical committee approval obtained from the Kent and Sussex
Health Authority and the Guy’s and St Thomas’s Hospital Trust, male and fe-
male patients were selected from those attending hospital based Rheumatol-
ogy clinics, as well as patients that were obtained directly from GP practices.
Patients were aged between 40 and 75 years. They had pain in one or both
knees most days for at least 1 month out of the 3 months prior to entering
the studies, and a standard radiographic appearance of knee OA consistent
with Kellgren and Lawrence grades I or II20,21.
Patients thus selected were recruited for radiography if at least one knee
had a diseased medial tibiofemoral compartment with a minimum JSW of at
least 2 mm, as measured from a macroradiograph obtained in the standing
semi-ﬂexed position. Knees were excluded if they showed evidence of unilat-
eralelateral compartment disease (i.e., if its JSW was narrower than the me-
dial compartment), marked chondrocalcinosis, other types of arthritis,
metabolic bone disease, previous trauma, or surgical intervention. Demo-
graphic information is presented in Table I.RADIOGRAPHYHigh deﬁnition macroradiographs, magniﬁcation 3.5e5.0, were taken of
the signal knee at baseline and at 2 years, using the SF positioning protocol
whereby each knee was positioned so that the tibial spines were centrally
placed relative to the femoral notch and then ﬂexed until the medial tibial pla-
teau was parallel to the horizontal central X-ray beam17. Radiographic mag-
niﬁcation was determined by attaching a metal ball (diameter 5.0 mm) to the
surface of the knee, prior to radiography. This method was based on that al-
ready being used for standard radiographs7 in which the metal ball was at-
tached to the skin above the head of the ﬁbula. Since a ball at this
location would not be visible in a microfocal radiograph, it was instead at-
tached above the tibial tuberosity. The magniﬁcation marker was therefore
magniﬁed by a different amount to the plane of JSW measurement, an offset
which had previously led to the metal ball method being eschewed in micro-
focal use7. To correct for this offset, a second radiograph was taken in the
lateral view at the same time, in the same degree of ﬂexion, and without mov-
ing the position of the metal ball, to determine the distance of the ball from
the plane of measurement and thus enable correct calculation of radio-
graphic magniﬁcation in that plane15. To determine measurement reproduc-
ibility for the new method, a subset of 26 knees was randomly selected (from
all knees X-rayed in the clinical trial) to have both lateral and semi-ﬂexed ra-
diographs repeated, on the same day and within a 2 h period.
The radiographic magniﬁcation was used to re-digitise each ﬁlm at a real
pixel size (in the plane of measurement) of 0.06 mm, using a Lumisys 200
laser ﬁlm digitiser (Lumisys Inc., Sunny Vale, CA).STANDARD RADIOGRAPHIC STUDIESBRISK study (Study S1)
Following ethical committee approval from theUKMulticentreResearch Eth-
ical Committee, male and female patients aged 40e80 inclusive with mild-to-
moderate medial compartment knee OA were recruited to this 1-year study at
10 radiographic sites in theUK22. Diagnosiswas according to the clinical and ra-
diological criteria of the American College of Rheumatology23. Radiographic in-
clusion criteria were a minimum medial JSW of between 2 and 4 mm, being
narrower than the lateral compartment of the sameknee, andat least one osteo-
phyte ineither tibiofemoralcompartment.Clinical inclusioncriteriawere thepres-
ence of daily knee pain for at least 1 month out of the 3 months prior to
recruitment and at least one of the following: age> 50 years, morning knee stiff-
nessofup to30 min,orkneecrepitus.Major exclusioncriteriawere thepresence
of non-OA causes of knee pain in the signal knee including rheumatic diseases
that could be responsible for secondary OA, history of knee surgery at any time,
use of intra-articular hyaluronic acid, use of bisphosphonates in the 12 months
332 R. J. Ward and J. C. Buckland-Wright: Rates of medial tibiofemoral JSN in OApreceding recruitment, knee injury or diagnostic arthroscopy in the preceding 6
months, and intra-articular corticosteroids in the preceding 3 months.
KOSTAR study (Study S2)
This was a 2 year multi-centre study using 42 radiographic sites in North
America (USA and Canada) and 44 sites in 11 European countries24,25. Fol-
lowing ethical approval from local committees or IRBs, male and female OA
patients aged 40e80 were recruited according to the criteria described
above for Study S1.
Both studies were conducted according to the International Conference
on Harmonization (ICH) guidelines for Good Clinical Practice (GCP). Demo-
graphic information for both studies is presented in Table I.RADIOGRAPHYStandard radiographs were taken of the signal knee at baseline and at the
end of the study, using the SF protocol17. Radiographic magniﬁcation was
determined by attaching a 5.0 mm metal ball to the skin above the head of
the ﬁbula so as to be close to the plane of JSW measurement. The radio-
graphic magniﬁcation was used to digitise each ﬁlm at a real pixel size of
0.08 mm. The testeretest standard deviation (SD) of JSW measurement us-
ing this method had previously been estimated at 0.19 mm with a 95% CI of
(0.13, 0.29)7.METHODS OF MEASUREMENT (ALL STUDIES)Table II
JSN and baseline JSW in the various studies
Study Baseline JSW (mm) JSN (mm/year)
Median (95% CI) Median (95% CI) Range
M 3.74 (3.63, 4.01) 0.02 (0.01, 0.08) (0.25, 1.01)
S1 3.17 (3.01, 3.29) 0.05 (0.02, 0.10) (0.60, 1.97)
S2 2.98 (2.90, 3.08) 0.02 (0.00, 0.05) (0.91, 1.75)All measurements were made using an image analysis suite named ‘Mdis-
play’, specially written in Cþþ and running on a Sun Sparc Ultra 2 workstation
(Sun Microsystems Ltd)15. This software incorporated a graphic user interface
(GUI) for interactive elements, as well as fully-automated implementations of
the detection and measurement algorithms as described below.
Magnification correction measurement
The diameters of the metal balls were measured using an iterative edge-
ﬁnding algorithm, which was initiated on being supplied with a ‘seed’ point
interior to the ball located using the automated algorithm. Following mea-
surement, a small image or ‘thumbnail’ of the ball with an overlay showing
the detected edge was saved. These thumbnails were reviewed by an oper-
ator, so as to verify that the algorithm had been successful. In rare cases
where the operator was unhappy with the fully-automated result, a seed point
was identiﬁed interactively within the Mdisplay GUI, a method with a 100%
success rate.
In the microfocal study, the magniﬁcation measured from the semi-ﬂexed
view radiograph was then adjusted using the distance between the metal ball
and the plane of JSW measurement as measured from the corresponding
lateral view radiograph.
JSW measurement
Minimum JSW in the medial compartment was measured using a new im-
plementation, in Mdisplay, of an existing semi-automated algorithm. This algo-
rithm used guide points marked by a trained operator to identify the tibial and
femoral margins, an edge-tracing stage to automatically delineate those mar-
gins, and a median-axis ﬁnding stage to measure the minimum distance be-
tween the margins all the way across the joint space26. Software
augmentations in Mdisplay provided the operator with the ability to redeﬁne
seed points and adjust the edge-tracing parameters, in cases where the auto-
matically traced edges could be seen to stray from the desired radiographic
features15. Operators were trained to recognise when a local minimum in inter-
bone distance was inappropriate to be used as the site of JSWmeasurement,
because it was too close to either the edge of the compartment, the medial tib-
ial spine, or a site of pathological change unrelated to cartilage loss (such as
an osteophyte)15.
The process of measuring JSW was speeded up using an algorithm which
automatically located the femoral and tibial condyles (ﬁrst using the previ-
ously determined location of the magniﬁcation marker to orient the algorithm)
and identiﬁed potential guide points. These guide points were then fed into
the JSW algorithm described above, so that the exact same minimum
JSW algorithm was used both in manual and fully-automated instances. A
thumbnail showing the edges detected, as well as the location of the mini-
mum JSW, was saved for review.
To ensure that each individual measurement was satisfactory, and that de-
cisions regarding correct placement of the minimum within the joint space
were consistent within knees, all JSW thumbnails underwent a quality control
review at the end of the study, in baselineeendpoint pairs with the operator
blinded to sequence. In cases where the operator was unhappy with the
thumbnail pair, interactive measurements within the Mdisplay GUI were re-
peated for one or both ﬁlms, and the resulting thumbnail pair sent for repeated
review.DATA ANALYSISFor the microfocal study, the testeretest reproducibility of JSW measure-
ment using the new method of magniﬁcation correction was calculated as the
median within knee SD from the 26 knees which had undergone repeat ra-
diography. This was then compared with the equivalent statistic from the pre-
vious wire mesh method.
For each study, the baseline JSW and the annual rate of JSN were calcu-
lated for each knee, and the averages for each of the three studies represented
as means or medians as appropriate to the data, together with 95% CIs calcu-
lated using distribution- or rank-based formulae, respectively14. For Study S2,
the European and North American arms of the study were ﬁrst analysed sep-
arately, so as to determine if there was any difference between them.
Reviews of published estimates of the annual rate of tibiofemoral JSN in
placebo-treated OA patients have been published in 199727 and 20028.
These reviews have been updated by adding more recently published esti-
mates, including those from the current investigation, but selecting only stud-
ies which reported minimum medial compartment JSW (as opposed to
similar measurements such as mean, area, or JSW measured at a speciﬁc
location), in order to present JSN ﬁgures which are more directly
comparable.
When absent from the original publications, CIs were estimated from pub-
lished ﬁgures for the mean, SD, and number of knees, using the standard for-
mula based on Student’s t statistic14. Publications which failed to provide
sufﬁcient data to calculate such an estimate were omitted from the review.ResultsREPRODUCIBILITY OF JSW MEASUREMENT FROM
MICROFOCAL RADIOGRAPHSThe median knee-wise SD (95% CI) of JSW measure-
ment measured from the 26 knees which had been radio-
graphed twice on the same day was 0.04 mm (0.03,
0.08), which was a signiﬁcant improvement (P¼ 0.002,
KruskaleWallis) over the estimate of 0.11 mm (0.08, 0.16)
previously obtained using the wire mesh method of radio-
graphic magniﬁcation measurement7.JSW AND JSNThe baseline JSW values and annual rates of JSN in the
studies are shown in Table II. Distributions of baseline
JSWs and rates of JSN were not normal and so medians
are shown together with 95% CIs. There were no differ-
ences between the ﬁgures for the North American and
European arms of Study S2, so combined data only are
presented.
Baseline JSW values were larger in Study M than in stud-
ies S1 and S2 (KruskaleWallis, P< 0.01), which is to be ex-
pected given that only the latter studies used an upper JSW
threshold for inclusion of knees into the study. However,
there were no signiﬁcant differences in rates of JSN
between any two of the median JSN ﬁgures in Table II
(KruskaleWallis, P> 0.2). In the larger standard radio-
graphic Study S2, a change in JSW over the course of
the study was detected which was signiﬁcant at the 95%
level, as shown by the CI in Table II.
The variability of the rates of JSN between studies were
compared using Brown and Forsythe’s modiﬁcation28 of
Levene’s test of absolute deviation from the median29.
JSN was found to be signiﬁcantly less variable in the
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graphic studies S1 and S2 (P< 0.02), while there was no
difference in JSN variability between studies S1 and S2
(P> 0.9). This is also reﬂected in the JSN ranges shown
in Table II.HISTORICAL REVIEW OF RATES OF JSNTable III lists the studies included in our review of rates of
change of minimum medial tibiofemoral JSW, with numbers
of knees, study duration, and essential methodological in-
formation (knee position and measurement method) to-
gether with statistics for baseline JSW and annual rate of
JSN. CIs for the rates of JSN are included, in recognition
of the fact that the variability of the rate is as signiﬁcant,
with regard to sample size, as the rate itself. Studies are
listed in chronological order, the last three are those being
presented here.
The large range and variety of methodological factors, to-
gether with differing baseline JSWs and statistical methods
(means vs medians) as well as the lack of raw data, pre-
clude detailed statistical analysis of how the various factors
shown in Table III might affect the rates of JSN. It is note-
worthy, however, that despite the differences between stud-
ies, and the CIs associated with rates of JSN show a good
degree of consistency. This is shown graphically in Fig. 1, in
which the JSN data-points for the different studies are
shape- and shading-coded according to the radiographic
view (knee position and use of ﬂuoroscopy, respectively).Discussion
The annual rates of JSN (Table II) were very consistent
across the three studies (no pairwise signiﬁcant differences,
KruskaleWallis). Variability in JSN was, however, signiﬁ-
cantly lower in the microfocal Study M than in either of
the standard radiographic studies (BrowneForsythe,
P< 0.02). This will have been largely due to the better re-
producibility of measurement from microfocal radiographs,Table I
Rates of change of radiographic tibiofemoral minimum JSW, 1992e2006
fluoroscopy, MTP¼MTP view. X-ray equipment: STD¼ standard; MF
have been estimated from published data where necessary. Po
Identiﬁer [reference] Number of
knees
Mean
duration (years)
Knee
position
M
A 30 150 3.0 Ext Ru
B 31 40 8.1 Ext Di
C 32 17 1.5 SF Co
D 33 55 1.0 Ext Le
E1 18 19 2.0 Ext Co
E2 18 19 2.0 LyS Co
F 34 139 5.0 Ext Le
G 35 71 3.0 ExF Co
H 36 214 2.6 Ext Le
I1 37 58 2.0 ExF Co
I2 37 58 2.0 LyS Co
J1 13 52 1.2 MTP Le
J2 13 52 1.2 SF Co
K 38 333 0.8 MTP Co
L 39 180 2.5 SF Le
M 36 2.0 SF Co
S1 86 1.1 SF Co
S2 549 2.1 SF Coas shown by the CIs for SD of repeated measures of
(0.03, 0.08) for microfocal and (0.13, 0.29) for standard
radiography. Other factors could include the fact that the
calculation of radiographic magniﬁcation was more reliable
because of the more consistent appearance of the edge of
the metal ball. This in turn was caused by the fact that the
X-ray beam passed through the knee as well as the ball,
allowing X-ray absorption by soft tissue to reduce burn-
out at the edge of the ball. It is also likely that in the smaller
microfocal study, conducted at a single site where the
methods were developed and well-established, there was
better consistency of radiographic technique particularly
with respect to knee-positioning compared to the multi-
centre standard radiographic studies S1 and S2. It can be
difﬁcult to maintain radiographic performance when using
a specialised method in multiple general radiography
departments, since there will be changes of staff and/or
equipment in at least some of those sites during the course
of a trial25. The promotion of a standardised knee-position-
ing protocol for general clinical use would help alleviate
such problems by making radiographers more generally
accustomed to the procedures required; the MTP view, as
a validated non-ﬂuoroscopic method needing no special-
ised equipment, has been proposed as the best candidate
for such use at this point in time40,41.IMPROVEMENTS TO MEASUREMENT METHODSOur ﬁndings regarding reproducibility of JSW measure-
ment from microfocal radiographs conﬁrm, since other fac-
tors were identical to previous studies7, that the metal ball
method of calculating radiographic magniﬁcation improved
the precision of the measurement compared to the previ-
ously published method using radiographic images of ﬁne
wire meshes attached to the anterior and posterior surfaces
of the knee7. This had been very difﬁcult to implement since
the images of the wire meshes often appeared in areas of
the radiographic image where the appearance of the trabec-
ular bone lattice had a similar pattern, making the meshes
difﬁcult to measure, and sometimes difﬁcult or evenII
. Knee positions, Ext¼ Fully extended, ExF¼ Fully extended with
R¼microfocal. Average figures are means or medians, and CIs
sitive values of JSN represent JSW decreasing overtime
easurement
method
Baseline JSW (mm) Annual JSN
Average (95% CI) Average (95% CI)
ler 0.61 (0.51, 0.71)
al calliper 0.10 (0.06, 0.14)
mputer 3.26 (2.96, 3.56) 0.18 (0.08, 0.28)
quesne 0.42 (0.12, 0.71)
mputer 3.80 (3.08, 4.52) 0.17 (0.01, 0.35)
mputer 2.90 (1.98, 3.82) 0.41 (0.07, 0.75)
quesne 4.1 (3.81, 4.39) 0.08 (0.05, 0.11)
mputer 4.01 (3.71, 4.31) 0.10 (0.01, 0.19)
quesne 3.86 (3.61, 4.11) 0.14 (0, 0.28)
mputer 3.56 (3.26, 3.86) 0.09 (0.01, 0.18)
mputer 2.92 (2.58, 3.26) 0.12 (0.05, 0.19)
quesne 4.17 (3.77, 4.57) 0.08 (0.24, 0.08)
mputer 3.90 (3.59, 4.21) 0.08 (0, 0.16)
mputer 3.49 (3.40, 3.57) 0.08 (0.01, 0.17)
quesne 3.61 (3.45, 3.77) 0.18 (0.14, 0.22)
mputer 3.74 (3.63, 4.01) 0.02 (0.01, 0.08)
mputer 3.17 (3.01, 3.29) 0.05 (0.17, 0.10)
mputer 2.98 (2.90, 3.08) 0.02 (0.00, 0.05)
Fig. 1. Rates of change of radiographic tibiofemoral minimum JSW, 1992e2006, in mm/year. See Table III for study details. Parenthesised
numbers are sample sizes.
334 R. J. Ward and J. C. Buckland-Wright: Rates of medial tibiofemoral JSN in OAimpossible to locate7,15. The introduction of ball-bearings as
magniﬁcation markers also facilitated the automation of that
measurement in addition to that of JSW15.
The use of lateral view radiographs to correct the magni-
ﬁcation measurement for the plane of measurement may,
however, not be necessary, due to the constant anatomical
relation between this plane and the position of the ball. Re-
sults from a study in which the lateral view radiograph was
eliminated suggest that doing so does indeed produce only
a small impairment of JSW reproducibility15.HISTORICAL REVIEW OF RATES OF CHANGE
OF MINIMUM JSWReviews of the results from different clinical trials, such as
presented in Table III and Fig. 1, run the risk of presenting the
results from studies conducted with quite different parame-
ters, as if they were directly comparable. For example, there
can be a lack of clinical homogeneity42, in that the patient
characteristics (including age, sex, and weight, and baseline
disease state) can have varied between studies. It is very dif-
ﬁcult to take account of such differences, since the effects of
patient characteristics on the progression of OA is, on the
whole, poorly understood43,44. The studies listed do, how-
ever, exhibit a fair and increasing degree of clinical homoge-
neity, due to the fact that the inclusion and exclusion criteria
for OA trials have become well standardised45.
The baseline JSW values shown in Table III vary from
3.26 to 4.17 mm. This range may be partly due to minor dif-
ferences in inclusion criteria (as in that between studies M
and S1/S2 mentioned above). But it will also be due to dif-
ferences in radiographic protocols, which have been shown
to have signiﬁcant effects on measurements of JSW7,11.
The method of measurement also varied between the stud-
ies listed in Table III. The earliest, in 199230, used direct
measurement with a ruler and produced a mean rate of
JSN signiﬁcantly and unrealistically higher than subsequent
studies (see Fig. 1). These subsequent studies used vari-
ants46,47 of the more sophisticated manual measurementmethod attributed to Lequesne5, and various computer-
assisted methods26,48. Computerised as opposed to
Lequesne measurement has also been shown to affect
the magnitude of JSW measurements7.
If the differences in baseline JSW between the various
studies listed are to some extent caused by radiographic
and mensural heterogeneity, then those heterogeneities
might also be expected to cause differences in rates of
JSN between those studies. However, estimates of tibiofe-
moral JSN are found to be fairly consistent between the var-
ious studies. The unscaled chronological x-axis of Fig. 1
enables one to see that, while earlier estimates of JSN var-
ied considerably and had large margins of error, as time has
gone by and standardisation of methods have improved, the
estimates of JSN have become more and more consistent.
Indeed, with one exception39 (shown as Study L in Table III
and Fig. 1), all estimates since the year 2000, regardless of
the knee view, measurement method, or inclusion criteria
used, have overlapped (all CIs containing the JSN value
0.05 mm/year). To date there have been no publications
suitable for inclusion in this review which have used the
‘ﬁxed-ﬂexion’ technique12,16 but, given the similarity of this
view to the MTP view9, there is no reason to expect such
investigations to produce results falling outside the general
trend seen in Table III and Fig. 1.
It is important to recognise that the measured rate of
JSN does not govern sample size calculations in isolation,
but rather in its ratio to the measured variance of that
rate14. This variance comprised components due to both
measurement reproducibility and the actual variance of
JSN in the population15. The large size of the population
component44, together with improvements in radiographic
and mensural procedures which have reduced the mea-
surement reproducibility component, have resulted in the
measured variance being dominated by the population var-
iance to such an extent that further efforts to improve mea-
surement reproducibility are likely to have little effect.
Furthermore, the similarity of rates of JSN using different
methodologies appear to be very similar as shown by the
335Osteoarthritis and Cartilage Vol. 16, No. 3overlapping CIs in Fig. 1. The practicability of JSN studies
may therefore be dependent more on the rate of JSN and
its variability in the population studied than on the choice
between competing but similarly effective radiographic
methodologies.
Rather than focussing solely onmeasurement and/or radio-
graphic procedures, another suggested approach to increas-
ing the rate of JSN in a trial, and hence its sensitivity to
therapeutic effect, is the careful selectionof patientswhomight
be expected to exhibit a high rate of disease progression49.
Study L in Table III and Fig. 1, the one study of recent years
which exhibited a clearly higher rate of JSN than the rest,
was an investigation into the effect of doxycycline treatment
on OA which took this approach by limiting recruitment to
obesewomen39 (a selection criterion suggested by the results
of the Chingford study50). While there have been questions
raised about the conclusions drawn from this trial24, it is clear
from Fig. 1 that the recruitment method was successful in se-
lecting a cohort which had a higher rate of JSN but without in-
creasing variability in that rate. The study provides evidence
that such an approach can be successful as far as increasing
the rate of JSN in the patient cohort is concerned, but any
method which restricts recruitment based on clinical factors
such as obesity could introduce new problems in interpreting
how the results would apply to the OA population in general.
Other clinical factors which have been shown to predict JSN
include baseline disease severity (radiographic features and
knee stiffness) and the presence of patellofemoral OA51.
The conclusion of this study is that the rate of JSN as
measured from high magniﬁcation microfocal radiographs
taken in the SF view did not differ from that measured
from standard radiographs, but the variability of the rate
was less using the microfocal method. There remains, how-
ever, the question of whether or not the reduction in re-
quired sample size afforded by microfocal radiography is
sufﬁcient to overcome the reduced practicability of the
method. This is a question which must be answered on
a case-by-case basis, but the scarcity of microfocal equip-
ment seems likely to continue to be a decisive factor. The
chief conclusion of the historical review of rates of JSN is
similar: that methodological differences between recent
studies have not produced signiﬁcantly different rates of
JSN. The variability of those rates can differ, but the size
of any such difference is strictly limited by the actual vari-
ability of JSN in the population: a component of the mea-
sured variability which has come to dominate that due to
measurement reproducibility more as methods have im-
proved. While microfocal equipment remains scarce, further
improvements to radiographic and mensural methods are
unlikely to have a large effect on required sample sizes in
clinical trials. It is our view that altering the ratio of variance
to mean rate of JSN by careful selection of patients is likely
to be a more fruitful direction for further research.References
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